COMUNICADO: Lanzamiento en Australia de Fycompa® (perampanel), tratamiento innovador contra la epilepsia (y 2)

  • 1. Australia Government, Department of Health. Pharmaceutical Benefits Scheme. Available at http://www.pbs.gov.au/pbs/home Accessed: October 2014 2. Rogawski MA. Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Currents 2011;11:56-63 3. ILAE/IBE/WHO, Epilepsy in the WHO European Region: Fostering Epilepsy Care in Europe 2010. Available at; http://www.ilae.org/Visitors/Documents/ILAEAnnual-Report2010Final_000.pdf Accessed: October 2014 4. Epilepsy Action Australia. Facts and statistics about Epilepsy. Available at: http://www.epilepsy.org.au/resources/for-media/facts-statistics-about-epilepsy Accessed: October 2014 5. French JA. Refractory Epilepsy; Clinical Overview. Epilepsia 2007: 48 (Suppl1) 3-7 6. French JA et al. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology 2012:79(6):589-596 7. French JA et al. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305. Epilepsia 2013:54(1):117-125 8. Krauss GM et al. Randomized phase III study 306: Adjunctive perampanel for refractory partial-onset seizures. Neurology 2012:78(18):1408-1415 9. Krauss GL et al. Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalised seizures: Results from Phase III extension study 307. Epilepsia 2014;55:1058-1068 10. Epilepsy in the WHO European Region: Fostering Epilepsy Care in Europe. http://www.ibe-epilepsy.org/downloads/EURO%20Report%20160510.pdf Accessed: October 2014 11. Pugliatti M et al. Estimating the cost of epilepsy in Europe: A review with economic modeling. Epilepsia 2007:48(12):2224-2233 Fecha de preparación: noviembre de 2014 Código de trabajo: Perampanel-UK2177a CONTACTO: Consultas de los medios de comunicación: Eisai Europe Ltd:Cressida Robson / Ben Speller, +44(0)7908-314-155 / +44(0)7908-409416,Cressida_Robson@eisai.net / Ben_Speller@eisai.net. Tonic LifeCommunications: Ainsley Cooper / Nicola Lilley, +44-(0)20-7798-9907 /+44-(0)207-798-9905, Ainsley.Cooper@toniclc.com /Nicola.Lilley@toniclc.com.

1. Australia Government, Department of Health. Pharmaceutical Benefits Scheme. Available at http://www.pbs.gov.au/pbs/home Accessed: October 2014 2. Rogawski MA. Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Currents 2011;11:56-63 3. ILAE/IBE/WHO, Epilepsy in the WHO European Region: Fostering Epilepsy Care in Europe 2010. Available at; http://www.ilae.org/Visitors/Documents/ILAEAnnual-Report2010Final_000.pdf Accessed: October 2014 4. Epilepsy Action Australia. Facts and statistics about Epilepsy. Available at: http://www.epilepsy.org.au/resources/for-media/facts-statistics-about-epilepsy Accessed: October 2014 5. French JA. Refractory Epilepsy; Clinical Overview. Epilepsia 2007: 48 (Suppl1) 3-7 6. French JA et al. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology 2012:79(6):589-596 7. French JA et al. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305. Epilepsia 2013:54(1):117-125 8. Krauss GM et al. Randomized phase III study 306: Adjunctive perampanel for refractory partial-onset seizures. Neurology 2012:78(18):1408-1415 9. Krauss GL et al. Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalised seizures: Results from Phase III extension study 307. Epilepsia 2014;55:1058-1068 10. Epilepsy in the WHO European Region: Fostering Epilepsy Care in Europe. http://www.ibe-epilepsy.org/downloads/EURO%20Report%20160510.pdf Accessed: October 2014 11. Pugliatti M et al. Estimating the cost of epilepsy in Europe: A review with economic modeling. Epilepsia 2007:48(12):2224-2233

Fecha de preparación: noviembre de 2014

Código de trabajo: Perampanel-UK2177aCONTACTO: Consultas de los medios de comunicación: Eisai Europe Ltd:Cressida Robson / Ben Speller, +44(0)7908-314-155 / +44(0)7908-409416,Cressida_Robson@eisai.net / Ben_Speller@eisai.net. Tonic LifeCommunications: Ainsley Cooper / Nicola Lilley, +44-(0)20-7798-9907 /+44-(0)207-798-9905, Ainsley.Cooper@toniclc.com /Nicola.Lilley@toniclc.com.

Mostrar comentarios